Michael T. Andriole - Net Worth and Insider Trading
Michael T. Andriole Net Worth
The estimated net worth of Michael T. Andriole is at least $8 Million dollars as of 2025-04-30. Michael T. Andriole is the PRESIDENT AND CEO of Chimerix Inc and owns about 609,603 shares of Chimerix Inc (CMRX) stock worth over $5 Million. Michael T. Andriole is also the CFO of Endocyte Inc and owns about 132,082 shares of Endocyte Inc (ECYT) stock worth over $3 Million. Details can be seen in Michael T. Andriole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael T. Andriole has not made any transactions after 2025-02-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Michael T. Andriole
Michael T. Andriole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael T. Andriole owns 2 companies in total, including Chimerix Inc (CMRX) , and Endocyte Inc (ECYT) .
Click here to see the complete history of Michael T. Andriole’s form 4 insider trades.
Insider Ownership Summary of Michael T. Andriole
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
CMRX | Chimerix Inc | 2025-02-13 | Chief Business Officer |
ECYT | Endocyte Inc | 2018-12-21 | Chief Financial Officer |
Michael T. Andriole Latest Holdings Summary
Michael T. Andriole currently owns a total of 2 stocks. Among these stocks, Michael T. Andriole owns 609,603 shares of Chimerix Inc (CMRX) as of February 13, 2025, with a value of $5 Million and a weighting of 62.16%. Michael T. Andriole also owns 132,082 shares of Endocyte Inc (ECYT) as of October 9, 2018, with a value of $3 Million and a weighting of 37.84%.
Latest Holdings of Michael T. Andriole
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CMRX | Chimerix Inc | 2025-02-13 | 609,603 | 8.54 | 5,206,010 |
ECYT | Endocyte Inc | 2018-10-09 | 132,082 | 23.99 | 3,168,647 |
Holding Weightings of Michael T. Andriole
Michael T. Andriole Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael T. Andriole has made a total of 5 transactions in Chimerix Inc (CMRX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Chimerix Inc is the sale of 7,370 shares on February 13, 2025, which brought Michael T. Andriole around $33,312.
According to the SEC Form 4 filings, Michael T. Andriole has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 17,918 shares on October 9, 2018, which brought Michael T. Andriole around $278,804.
Insider Trading History of Michael T. Andriole
- 1
Michael T. Andriole Trading Performance
GuruFocus tracks the stock performance after each of Michael T. Andriole's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael T. Andriole is 60.17%. GuruFocus also compares Michael T. Andriole's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael T. Andriole within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael T. Andriole's insider trading performs compared to the benchmark.
Performance of Michael T. Andriole
Michael T. Andriole Ownership Network
Ownership Network List of Michael T. Andriole
Ownership Network Relation of Michael T. Andriole

Michael T. Andriole Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Michael T. Andriole is the Chief Business Officer of Chimerix Inc. Other key executives at Chimerix Inc include Principal Accounting Officer David Jakeman , Chief Medical Officer Allen S. Melemed , and Principal Executive Officer Michael Albert Alrutz .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Michael T. Andriole made 4 insider transaction in Chimerix Inc (CMRX) with a net sale of 12,749. Other recent insider transactions involving Chimerix Inc (CMRX) include a net sale of 5,760 shares made by David Jakeman , a net sale of 5,215 shares made by , and a net purchase of 20,000 shares made by Fred A Middleton .
In summary, during the past 3 months, insiders sold 14,595 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 14,595 shares. During the past 18 months, 28,389 shares of Chimerix Inc (CMRX) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 8,389 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Michael T. Andriole Mailing Address
Above is the net worth, insider trading, and ownership report for Michael T. Andriole. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael T. Andriole's mailing address is: West Lafayette In 47906.